PDCD1 and neoplasm: Neoantigen epitope protein sequence formed by tumor‐specific DNA mutation, which regulates the differentiation of TIL (tumor infiltrating lymphocytes), is a necessary condition for the effectiveness of PD‐1/PD‐L1 monoclonal antibody.